丹麦的头癌趋势:一个全国性的40年数据分析
Kathrine K Jakobsen1, Jacob H Rasmussen1, Jacob Melchiors1
1Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Oral oncology
|December 31, 2025
概括
丹麦的头癌 (HNC) 发病率正在上升,但总体而言,生存率正在改善. 存活率因癌症亚部位而异,需要进一步研究和治疗降级策略.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 头癌 (HNCs) 代表了一组多样化的恶性瘤.
- 在HNC解剖部位,组织学和患者生存结果中存在显著差异.
研究的目的:
- 分析丹麦的头癌发病率和生存趋势.
- 为从1980年到2021年提供有关HNC流行病学的见解.
主要方法:
- 使用丹麦癌症登记处和中央人口登记处数据进行的回顾性队列研究.
- 包括所有上空消化道HNC病例从1980年到2021年.
- 计算了年龄调整的发病率和相对存活率;通过线性回归来确定年平均百分比变化 (AAPC).
主要成果:
- 总共分析了36626个HNC案件.
- 根据年龄调整的发病率 (AAIR) 在1980年至2021年之间从每10万人口中的7.1增加到12.5
- 口癌在2015-2021年最常见,5年生存率最高 (70.1%),口癌最常见 (26.8%).
- 总体而言,5年相对存活率从46.9% (1980-1984) 提高到65.2% (2015-2019).
结论:
- 在丹麦,HNC的发病率继续上升,伴随着生存率的提高.
- 在不同HNC子站点之间存在显著的生存差异.
- 进一步的研究和治疗降级对于改善治疗结果和幸存者的生活质量至关重要.
相关概念视频
Cancer
51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Cancers Originate from Somatic Mutations in a Single Cell
12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Comparing the Survival Analysis of Two or More Groups
712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863


